Pharma ad tech gains traction, threatening legacy DSPs and SSPs — implications for digital marketing budgets.

Context

Pharma ad tech is gaining momentum, with insiders suggesting it may come at the cost of legacy platforms like DSPs and SSPs. This shift could have significant implications for digital marketing budgets, as pharma companies increasingly prioritize targeted advertising. Relevant for marketers working with pharma clients or evaluating the impact of ad tech on their budgets.